BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 24892333)

  • 1. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
    Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
    J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
    J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric and radiobiological comparison of prostate VMAT plans optimized using the photon and progressive resolution algorithm.
    Chow JCL; Jiang R; Xu L
    Med Dosim; 2020 Spring; 45(1):14-18. PubMed ID: 31103251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of VMAT Planning Strategies for Prostate Patients with Bilateral Hip Prosthesis.
    To D; Xhaferllari I; Liu M; Liang J; Knill C; Nandalur S; Gustafson G; Lack D
    Technol Cancer Res Treat; 2021; 20():15330338211038490. PubMed ID: 34490809
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosimetric comparison of analytical anisotropic algorithm and the two dose reporting modes of Acuros XB dose calculation algorithm in volumetric modulated arc therapy of carcinoma lung and carcinoma prostate.
    Gopalakrishnan Z; Bhasi S; P R; Menon SV; B S; Thayil AG; Nair RK
    Med Dosim; 2022 Autumn; 47(3):280-287. PubMed ID: 35690544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
    Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
    World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mixed energy partial arcs for volumetric modulated arc therapy for prostate cancer.
    Momin S; Gräfe JL; Khan RF
    J Appl Clin Med Phys; 2019 Apr; 20(4):51-65. PubMed ID: 30861308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.
    Pasler M; Georg D; Wirtz H; Lutterbach J
    Strahlenther Onkol; 2011 Dec; 187(12):792-8. PubMed ID: 22127357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
    Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
    J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of biological versus physical optimization for single-arc VMAT for prostate and head and neck cases.
    Pyshniak V; Fotina I; Zverava A; Siamkouski S; Zayats E; Kopanitsa G; Okuntsau D
    J Appl Clin Med Phys; 2014 Jul; 15(4):4514. PubMed ID: 25207394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment planning comparison between dynamic wave arc and volumetric modulated arc therapies for prostate-cancer treatment.
    Miura H; Nakao M; Doi Y; Ozawa S; Kenjo M; Nagata Y
    Med Dosim; 2022 Spring; 47(1):48-53. PubMed ID: 34538693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans.
    Bazalova-Carter M; Qu B; Palma B; Hårdemark B; Hynning E; Jensen C; Maxim PG; Loo BW
    Med Phys; 2015 May; 42(5):2615-25. PubMed ID: 25979053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
    Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse.
    Peters S; Schiefer H; Plasswilm L
    Radiat Oncol; 2014 Jul; 9():153. PubMed ID: 25011529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
    Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
    Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.
    Bartlett GK; Njeh CF; Huang KC; DesRosiers C; Guo G
    Med Dosim; 2023 Spring; 48(1):8-15. PubMed ID: 36319515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
    Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
    J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.